Copyright
©The Author(s) 2020.
World J Stem Cells. Apr 26, 2020; 12(4): 241-250
Published online Apr 26, 2020. doi: 10.4252/wjsc.v12.i4.241
Published online Apr 26, 2020. doi: 10.4252/wjsc.v12.i4.241
Letter | Relates to | Classification |
A | BMA | 1 – Collection and injection |
2 – Description of harvesting | ||
3 – Cell count | ||
4 – Dosage of cytokines (GF and/or IL) | ||
5 – CFU | ||
6 - MSC and HSC phenotyping | ||
7- Differentiation evaluation | ||
8 – Functional assays | ||
C | BMAC | 1 – Collection and injection |
2 – Description of harvesting | ||
3 – Cell count | ||
4 – Dosage of cytokines (GF and/or IL) | ||
5 - CFU | ||
6 – HSC and/or MSC phenotyping | ||
7 – Differentiation evaluation | ||
8 – Functional Assays | ||
H | BMA + BMAC used together | 1 – Collection and injection |
2 – Description of harvesting | ||
3 – Cell count | ||
4 – Dosage of cytokines (GF and/or IL) | ||
5 - CFU | ||
6 – HSC and/or MSC phenotyping | ||
7 – Differentiation evaluation | ||
8 – Functional assays |
- Citation: Purita J, Lana JFSD, Kolber M, Rodrigues BL, Mosaner T, Santos GS, Caliari-Oliveira C, Huber SC. Bone marrow-derived products: A classification proposal – bone marrow aspirate, bone marrow aspirate concentrate or hybrid? World J Stem Cells 2020; 12(4): 241-250
- URL: https://www.wjgnet.com/1948-0210/full/v12/i4/241.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v12.i4.241